Clinical Trial Update: Haemochromatosis:Phlebotomy Versus Erythrocytapheresis Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial comparing phlebotomy and erythrocytapheresis for hemochromatosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemochromatosis

Snippet

Sponsor: Sanquin Research & Blood Bank Divisions | Conditions: Hemochromatosis | Phase 3 | Status: COMPLETED